Physician profile
Steven G Coca
NPI 1700972346
$444,753.03
in general payments reported to CMS, 2019-2025
11 companies · $76K in 2025
The $76K reported for 2025 was more than what 99% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,086 · 2020: $9,825 · 2021: $7,928 · 2022: $134K · 2023: $102K · 2024: $112K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $274K · Travel and Lodging: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $274,326.07 |
| Travel and Lodging | $12,539.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $1,307.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $307,485.47 | 2022-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Alexion Pharmaceuticals, INC. | $42,163.56 | 2024 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31,194.27 | 2020-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $27,811.62 | 2019-2025 | |
| Nuwellis, INC. | $15,100.00 | 2019-2025 | Aquadex Smartflow Console |
| Vifor Pharma, INC. | $9,127.50 | 2020-2022 | |
| Boehringer Ingelheim International Gmbh | $9,056.87 | 2021-2022 | |
| Scpharmaceuticals INC. | $1,200.00 | 2024 | |
| Fresenius USA Marketing, INC. | $1,000.00 | 2019 | |
| Astrazeneca Uk Limited | $490.00 | 2025 | Farxiga |
| Amgen INC. | $123.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Coca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.